<code id='F97DA07FC4'></code><style id='F97DA07FC4'></style>
    • <acronym id='F97DA07FC4'></acronym>
      <center id='F97DA07FC4'><center id='F97DA07FC4'><tfoot id='F97DA07FC4'></tfoot></center><abbr id='F97DA07FC4'><dir id='F97DA07FC4'><tfoot id='F97DA07FC4'></tfoot><noframes id='F97DA07FC4'>

    • <optgroup id='F97DA07FC4'><strike id='F97DA07FC4'><sup id='F97DA07FC4'></sup></strike><code id='F97DA07FC4'></code></optgroup>
        1. <b id='F97DA07FC4'><label id='F97DA07FC4'><select id='F97DA07FC4'><dt id='F97DA07FC4'><span id='F97DA07FC4'></span></dt></select></label></b><u id='F97DA07FC4'></u>
          <i id='F97DA07FC4'><strike id='F97DA07FC4'><tt id='F97DA07FC4'><pre id='F97DA07FC4'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:388

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

          Relive this year’s J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for the year ahead.

          advertisement

          Sponsor introduction

          • John Arena, SVP, enterprise strategy & solutions, Cencora

          Featured speakers

          • Tara Bannow, hospitals and insurance reporter, STAT
          • Damian Garde, national biotech reporter, STAT
          • Matthew Herper, senior writer, medicine; editorial director of events, STAT
          • Allison DeAngelis, biotech startups and venture capital reporter, STAT (moderator)

          Sponsored By

          Cencora

          leisure time

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          Prime Medicine, Myeloid Therapeutics clash over genome
          Prime Medicine, Myeloid Therapeutics clash over genome

          AdobeThecloselywatchedgene-editingstartupPrimeMedicineisembroiledinamultimillion-dollardisputewithan

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          'A game

          BillSikes/APOnMonday,VertexPharmaceuticalssecuredapprovalofanewcysticfibrosisdrug.MargotClevelandbou